Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewed
The SUMOylation inhibitor TAK-981 (Subasumstat) triggers IFN-I-dependent activation of Natural Killer cells against Acute Myeloid Leukemias.
Rawan Hallal, Marion de Toledo, Denis Tempé…·Guillaume Bossis
This paper shows that TAK-981 activates NK cells against AML by inducing IFN-I secretion, enhancing their cytotoxicity and cytokine production.
5 citations